Evogene Ltd (EVGN)

Evogene Ltd witnessed notable insider trading activity recently, with Leon Recanati acquiring shares valued at approximately 692,100 USD across two August transactions. These purchases occurred shortly before the company reported its latest earnings results. Despite a 2.3 percent decline in stock price over the past ninety days, these acquisitions represent a significant increase in insider holdings.
Ticker: EVGN Exchange: NAS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Evogene Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
RECANATI LEON Non-Executive Director
Transaction date
Purchase
Price
365.61
Quantity 50,877 +31.6%
Value US$3,300,558
RECANATI LEON Non-Executive Director
Transaction date
Purchase
Price
350.78
Quantity 28,769 -38.3%
Value US$2,801,797
Tarcic Gabi Chief Development Officer Officer
Transaction date
Purchase
Price
415.49
Quantity 48,140 +41.6%
Value US$2,126,423
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-13 2026-08-11 B Purchase Non-Executive Director
50,877 +31.6%
365.61
US$3,300,558
50,877 +31.6% 365.61 US$3,300,558
2026-08-05 2026-08-04 B Purchase Non-Executive Director
28,769 -38.3%
350.78
US$2,801,797
28,769 -38.3% 350.78 US$2,801,797
2026-08-26 2026-06-04 B Purchase

Chief Development Officer

Officer
48,140 +41.6%
415.49
US$2,126,423
48,140 +41.6% 415.49 US$2,126,423